165 related articles for article (PubMed ID: 34243826)
1. Measuring Patient Preferences at the FDA Center for Devices and Radiological Health: Reflections and Projections.
Webber CM; Chen AL; Gebben DJ; Saha A; Tarver ME
Value Health; 2021 Jul; 24(7):1024-1029. PubMed ID: 34243826
[TBL] [Abstract][Full Text] [Related]
2. Integrating the Voice of the Patient Into the Medical Device Regulatory Process Using Patient Preference Information.
Benz HL; Saha A; Tarver ME
Value Health; 2020 Mar; 23(3):294-297. PubMed ID: 32197723
[TBL] [Abstract][Full Text] [Related]
3. The Center for Devices and Radiological health: an update.
Donawa M
Med Device Technol; 2001 Dec; 12(10):24, 26-7. PubMed ID: 15966141
[TBL] [Abstract][Full Text] [Related]
4. [Discussion of Enlightenment from the Reorganization of CDRH Regulatory for Medical Device].
Shang H; Zhang S
Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Feb; 44(2):154-157. PubMed ID: 32400990
[TBL] [Abstract][Full Text] [Related]
5. Regulatory Considerations for Physiological Closed-Loop Controlled Medical Devices Used for Automated Critical Care: Food and Drug Administration Workshop Discussion Topics.
Parvinian B; Scully C; Wiyor H; Kumar A; Weininger S
Anesth Analg; 2018 Jun; 126(6):1916-1925. PubMed ID: 28763355
[TBL] [Abstract][Full Text] [Related]
6. Patient Preferences in Regulatory Benefit-Risk Assessments: A US Perspective.
Johnson FR; Zhou M
Value Health; 2016; 19(6):741-745. PubMed ID: 27712700
[TBL] [Abstract][Full Text] [Related]
7. The nightmare of FDA clearance/approval to market: perception or reality?
Tylenda CA
Technol Health Care; 1996 Sep; 4(3):259-67. PubMed ID: 8931236
[TBL] [Abstract][Full Text] [Related]
8. A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical Technologies.
Ho M; Saha A; McCleary KK; Levitan B; Christopher S; Zandlo K; Braithwaite RS; Hauber AB;
Value Health; 2016; 19(6):746-750. PubMed ID: 27712701
[TBL] [Abstract][Full Text] [Related]
9. Incorporating patient-preference evidence into regulatory decision making.
Ho MP; Gonzalez JM; Lerner HP; Neuland CY; Whang JM; McMurry-Heath M; Hauber AB; Irony T
Surg Endosc; 2015 Oct; 29(10):2984-93. PubMed ID: 25552232
[TBL] [Abstract][Full Text] [Related]
10. Interventional cardiology live case presentations regulatory considerations.
Farb A; Brown SA; Wolf DA; Zuckerman B
Heart Rhythm; 2010 Oct; 7(10):e1-3. PubMed ID: 20869626
[TBL] [Abstract][Full Text] [Related]
11. ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products.
O'Neill T; Miksad R; Miller D; Maloney L; John A; Hiller C; Hornberger J
Value Health; 2019 Jul; 22(7):754-761. PubMed ID: 31277820
[TBL] [Abstract][Full Text] [Related]
12. Awareness of the role of science in the FDA regulatory submission process: a survey of the TERMIS-Americas membership.
Johnson PC; Bertram TA; Carty NR; Hellman KB; Tawil BJ; Van Dyke M
Tissue Eng Part A; 2014 Jun; 20(11-12):1565-82. PubMed ID: 24665855
[TBL] [Abstract][Full Text] [Related]
13. Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule.
Fed Regist; 1994 Jun; 59(116):31138. PubMed ID: 10136908
[TBL] [Abstract][Full Text] [Related]
14. Qualification of a non-animal vaginal irritation method admitted as nonclinical assessment model (NAM) in the Incubator Phase of the United States Food and Drug Administration (US FDA) Medical Devices Development Tool (MDDT).
Costin GE; Hill E; Brown J; Clippinger AJ
Toxicol In Vitro; 2020 Feb; 62():104680. PubMed ID: 31626901
[TBL] [Abstract][Full Text] [Related]
15. Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule.
Fed Regist; 1998 May; 63(95):27207-8. PubMed ID: 10179344
[TBL] [Abstract][Full Text] [Related]
16. The medical device development ecosystem: Current regulatory state and challenges for future development: A review.
Holmes DR; Farb A; Dib N; Jacques L; Rowe S; DeMaria A; King S; Zuckerman B
Cardiovasc Revasc Med; 2024 Mar; 60():95-101. PubMed ID: 37778922
[TBL] [Abstract][Full Text] [Related]
17. Technology assessment of medical devices at the Center for Devices and Radiological Health.
Kessler L; Richter K
Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
[TBL] [Abstract][Full Text] [Related]
18. FDA adverse Event Problem Codes: standardizing the classification of device and patient problems associated with medical device use.
Reed TL; Kaufman-Rivi D
Biomed Instrum Technol; 2010; 44(3):248-56. PubMed ID: 20715359
[TBL] [Abstract][Full Text] [Related]
19. Interventional cardiology live case presentations: regulatory considerations.
Farb A; Brown SA; Wolf DA; Zuckerman B
Catheter Cardiovasc Interv; 2010 Oct; 76(4):E126-9. PubMed ID: 20862708
[TBL] [Abstract][Full Text] [Related]
20. The new collaborative path in medical device development: the medical device innovation consortium.
Kampfrath T; Cotten SW
Clin Biochem; 2013 Oct; 46(15):1320-2. PubMed ID: 23578741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
